{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:40:18Z","timestamp":1759408818624,"version":"build-2065373602"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-06062-0","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:03:33Z","timestamp":1759406613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The timing of using IVIG for neonatal ABO hemolytic disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Na","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"6062_CR1","unstructured":"Woodgate P, Jardine LA. Neonatal jaundice. BMJ Clin Evid. 2011;2011:0319."},{"issue":"4","key":"6062_CR2","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1542\/peds.110.4.e47","volume":"110","author":"M Kaplan","year":"2002","unstructured":"Kaplan M, Muraca M, Hammerman C, et al. Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice. Pediatrics. 2002;110(4):e47.","journal-title":"Pediatrics"},{"issue":"4","key":"6062_CR3","doi-asserted-by":"publisher","first-page":"e2023063323","DOI":"10.1542\/peds.2023-063323","volume":"153","author":"L Sarathy","year":"2024","unstructured":"Sarathy L, Chou JH, Romano-Clarke G, Darci KA, Lerou PH. Bilirubin measurement and phototherapy use after the AAP 2022 newborn hyperbilirubinemia guideline. Pediatrics. 2024;153(4):e2023063323.","journal-title":"Pediatrics"},{"issue":"1","key":"6062_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12887-025-05464-4","volume":"25","author":"A Kassie","year":"2025","unstructured":"Kassie A, Berta DM, Yalew A, Sitotaw C, Workineh M, Woldu B. Hematological parameter changes and associated factors in neonates with hyperbilirubinemia treated with phototherapy. BMC Pediatr. 2025;25(1):115.","journal-title":"BMC Pediatr"},{"issue":"8","key":"6062_CR5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S2352-4642(18)30139-1","volume":"2","author":"BO Olusanya","year":"2018","unstructured":"Olusanya BO, Kaplan M, Hansen T. Neonatal hyperbilirubinaemia: a global perspective. Lancet Child Adolesc Health. 2018;2(8):610\u201320.","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"6062_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jpeds.2012.08.022","volume":"162","author":"VK Bhutani","year":"2013","unstructured":"Bhutani VK, Stark AR, Lazzeroni LC, et al. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr. 2013;162(3):477\u2013e4821.","journal-title":"J Pediatr"},{"issue":"3","key":"6062_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.siny.2006.02.002","volume":"11","author":"H Smitherman","year":"2006","unstructured":"Smitherman H, Stark AR, Bhutani VK. Early recognition of neonatal hyperbilirubinemia and its emergent management. Semin Fetal Neonatal Med. 2006;11(3):214\u201324.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"3","key":"6062_CR8","first-page":"CD008168","volume":"3","author":"SB Gottimukkala","year":"2023","unstructured":"Gottimukkala SB, Lobo L, Gautham KS, Bolisetty S, Fiander M, Schindler T. Intermittent phototherapy versus continuous phototherapy for neonatal jaundice. Cochrane Database Syst Rev. 2023;3(3):CD008168.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"6062_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41390-020-01232-5","volume":"90","author":"GR Krog","year":"2021","unstructured":"Krog GR, Donneborg ML, Hansen BM, et al. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A\/anti-B IgG titer. Pediatr Res. 2021;90(1):74\u201381.","journal-title":"Pediatr Res"},{"issue":"1","key":"6062_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/bjh.18170","volume":"198","author":"L Lieberman","year":"2022","unstructured":"Lieberman L, Lopriore E, Baker JM, et al. International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn. Br J Haematol. 2022;198(1):183\u201395.","journal-title":"Br J Haematol"},{"issue":"2","key":"6062_CR11","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1542\/peds.2005-2084","volume":"117","author":"E Hank\u00f8","year":"2006","unstructured":"Hank\u00f8 E. Unbound bilirubin and risk assessment in the jaundiced newborn: possibilities and limitations. Pediatrics. 2006;117(2):526\u20137.","journal-title":"Pediatrics"},{"issue":"2","key":"6062_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.clp.2016.01.001","volume":"43","author":"VK Bhutani","year":"2016","unstructured":"Bhutani VK, Wong RJ, Stevenson DK. Hyperbilirubinemia in preterm neonates. Clin Perinatol. 2016;43(2):215\u201332.","journal-title":"Clin Perinatol"},{"issue":"3","key":"6062_CR13","first-page":"199","volume":"13","author":"JB Le Pichon","year":"2017","unstructured":"Le Pichon JB, Riordan SM, Watchko J, Shapiro SM. The neurological sequelae of neonatal hyperbilirubinemia: definitions, diagnosis and treatment of the Kernicterus spectrum disorders (KSDs). Curr Pediatr Rev. 2017;13(3):199\u2013209.","journal-title":"Curr Pediatr Rev"},{"issue":"9","key":"6062_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1440-1754.2011.02217.x","volume":"48","author":"A McGillivray","year":"2012","unstructured":"McGillivray A, Evans N. Severe neonatal jaundice: is it a rare event in Australia. J Paediatr Child Health. 2012;48(9):801\u20137.","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"6062_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/apa.14141","volume":"107","author":"K Mreihil","year":"2018","unstructured":"Mreihil K, Benth J\u0160, Stensvold HJ, et al. Phototherapy is commonly used for neonatal jaundice but greater control is needed to avoid toxicity in the most vulnerable infants. Acta Paediatr. 2018;107(4):611\u20139.","journal-title":"Acta Paediatr"},{"key":"6062_CR16","doi-asserted-by":"publisher","unstructured":"Alcock GS, Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev. 2002;(3).\u00a0https:\/\/doi.org\/10.1002\/14651858.CD003313.","DOI":"10.1002\/14651858.CD003313"},{"issue":"3","key":"6062_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/jmf.16.3.163.166","volume":"16","author":"AM Miqdad","year":"2004","unstructured":"Miqdad AM, Abdelbasit OB, Shaheed MM, Seidahmed MZ, Abomelha AM, Arcala OP. Intravenous Immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. J Matern Fetal Neonatal Med. 2004;16(3):163\u20136.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"6062_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1542\/peds.114.1.297","volume":"114","author":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia","year":"2004","unstructured":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297\u2013316.","journal-title":"Pediatrics"},{"issue":"6","key":"6062_CR19","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/s41390-023-02712-0","volume":"94","author":"S Rasiah","year":"2023","unstructured":"Rasiah S, Jegathesan T, Campbell DM, Shah PS, Sgro MD. Intravenous Immunoglobulin G therapy for neonatal hyperbilirubinemia. Pediatr Res. 2023;94(6):2092\u20137.","journal-title":"Pediatr Res"},{"key":"6062_CR20","first-page":"CD003313","volume":"3","author":"C Zwiers","year":"2018","unstructured":"Zwiers C, Scheffer-Rath ME, Lopriore E, de Haas M, Liley HG. Immunoglobulin for alloimmune hemolytic disease in neonates. Cochrane Database Syst Rev. 2018;3:CD003313.","journal-title":"Cochrane Database Syst Rev"},{"key":"6062_CR21","doi-asserted-by":"crossref","unstructured":"Kemper AR, Newman TB, Slaughter JL et al. Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2022;150(3):e2022058859.","DOI":"10.1542\/peds.2022-058865"},{"issue":"1","key":"6062_CR22","doi-asserted-by":"publisher","first-page":"e040182","DOI":"10.1136\/bmjopen-2020-040182","volume":"11","author":"M Zhang","year":"2021","unstructured":"Zhang M, Tang J, He Y, et al. Systematic review of global clinical practice guidelines for neonatal hyperbilirubinemia. BMJ Open. 2021;11(1):e040182.","journal-title":"BMJ Open"},{"issue":"9","key":"6062_CR23","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.arcped.2014.02.005","volume":"21","author":"A Cortey","year":"2014","unstructured":"Cortey A, Elzaabi M, Waegemans T, Roch B, Aujard Y. [Efficacy and safety of intravenous Immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis]. Arch Pediatr. 2014;21(9):976\u201383.","journal-title":"Arch Pediatr"},{"issue":"1","key":"6062_CR24","doi-asserted-by":"publisher","first-page":"F6","DOI":"10.1136\/fn.88.1.F6","volume":"88","author":"R Gottstein","year":"2003","unstructured":"Gottstein R, Cooke RW. Systematic review of intravenous Immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed. 2003;88(1):F6\u201310.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"6","key":"6062_CR25","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s12185-011-0853-4","volume":"93","author":"G Demirel","year":"2011","unstructured":"Demirel G, Akar M, Celik IH, et al. Single versus multiple dose intravenous Immunoglobulin in combination with LED phototherapy in the treatment of ABO hemolytic disease in neonates. Int J Hematol. 2011;93(6):700\u20133.","journal-title":"Int J Hematol"},{"issue":"1","key":"6062_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1542\/peds.2009-0676","volume":"125","author":"J Figueras-Aloy","year":"2010","unstructured":"Figueras-Aloy J, Rodr\u00edguez-Migu\u00e9lez JM, Iriondo-Sanz M, Salvia-Roiges MD, Botet-Mussons F, Carbonell-Estrany X. Intravenous Immunoglobulin and necrotizing Enterocolitis in newborns with hemolytic disease. Pediatrics. 2010;125(1):139\u201344.","journal-title":"Pediatrics"},{"issue":"18","key":"6062_CR27","first-page":"3902","volume":"20","author":"Y Yang","year":"2016","unstructured":"Yang Y, Pan JJ, Zhou XG, Zhou XY, Cheng R, Hu YH. The effect of Immunoglobulin treatment for hemolysis on the incidence of necrotizing enterocolitis - a meta-analysis. Eur Rev Med Pharmacol Sci. 2016;20(18):3902\u201310.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"6062_CR28","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.3109\/14767058.2012.718387","volume":"25","author":"L Corvaglia","year":"2012","unstructured":"Corvaglia L, Legnani E, Galletti S, Arcuri S, Aceti A, Faldella G. Intravenous Immunoglobulin to treat neonatal alloimmune haemolytic disease. J Matern Fetal Neonatal Med. 2012;25(12):2782\u20135.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"12","key":"6062_CR29","first-page":"1827","volume":"27","author":"F Nasseri","year":"2006","unstructured":"Nasseri F, Mamouri GA, Babaei H. Intravenous Immunoglobulin in ABO and Rh hemolytic diseases of newborn. Saudi Med J. 2006;27(12):1827\u201330.","journal-title":"Saudi Med J"},{"key":"6062_CR30","doi-asserted-by":"publisher","unstructured":"Slaughter JL, Kemper AR, Newman TB. Technical report: diagnosis and management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2022;150(3).https:\/\/doi.org\/10.1542\/peds.2022-058865 .","DOI":"10.1542\/peds.2022-058865"},{"issue":"4","key":"6062_CR31","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1542\/peds.2010-3242","volume":"127","author":"VE Smits-Wintjens","year":"2011","unstructured":"Smits-Wintjens VE, Walther FJ, Rath ME, et al. Intravenous Immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial. Pediatrics. 2011;127(4):680\u20136.","journal-title":"Pediatrics"},{"issue":"4","key":"6062_CR32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1537-2995.2012.03827.x","volume":"53","author":"MC Santos","year":"2013","unstructured":"Santos MC, S\u00e1 C, Gomes SC Jr, Camacho LA, Moreira ME. The efficacy of the use of intravenous human Immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial. Transfusion. 2013;53(4):777\u201382.","journal-title":"Transfusion"},{"issue":"4","key":"6062_CR33","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1542\/peds.109.4.e53","volume":"109","author":"SU Sarici","year":"2002","unstructured":"Sarici SU, Yurdak\u00f6k M, Serdar MA, et al. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Pediatrics. 2002;109(4):e53.","journal-title":"Pediatrics"},{"issue":"9","key":"6062_CR34","first-page":"685","volume":"48","author":"Editorial Board of Chinese Journal of Pediatrics, Subspecialty Group of Neonatology TSoP, Chinese Medical Association","year":"2010","unstructured":"Editorial Board of Chinese Journal of Pediatrics, Subspecialty Group of Neonatology TSoP, Chinese Medical Association. [Experts consensus on principles for diagnosis and treatment of neonatal jaundice]. Zhonghua Er Ke Za Zhi. 2010;48(9):685\u20136.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"6","key":"6062_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/tropej\/fmaa016","volume":"66","author":"NY Boo","year":"2020","unstructured":"Boo NY, Sin S, Chee SC, et al. Genetic factors and delayed TSB monitoring and treatment as risk factors associated with severe hyperbilirubinemia in term neonates admitted for phototherapy. J Trop Pediatr. 2020;66(6):569\u201382.","journal-title":"J Trop Pediatr"},{"issue":"5","key":"6062_CR36","first-page":"1113","volume":"30","author":"A Bulbul","year":"2014","unstructured":"Bulbul A, Cayonu N, Sanli ME, Uslu S. Evaluation of risk factors for development of severe hyperbilirubinemia in term and near term infants in Turkey. Pak J Med Sci. 2014;30(5):1113\u20138.","journal-title":"Pak J Med Sci"},{"issue":"3","key":"6062_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.17992\/lbl.2020.03.473","volume":"106","author":"AU Bergmann","year":"2020","unstructured":"Bergmann AU, Thorkelsson T. [Incidence and risk factors for severe hyperbilirubinemia in term neonates]. Laeknabladid. 2020;106(3):139\u201343.","journal-title":"Laeknabladid"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06062-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-06062-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06062-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:03:36Z","timestamp":1759406616000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-06062-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6062"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-06062-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki(as was revised in 2013). The study was approved by Ethics Committee of the West China Second University Hospital, Sichuan University. We obtained written informed consent from legal guardians for all participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"731"}}